WHO approves Bavarian Nordic's mpox vaccine for adolescents-June 2024-www.financetom.com

WHO approves Bavarian Nordic's mpox vaccine for adolescents

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

WHO approves Bavarian Nordic's mpox vaccine for adolescents

Oct 14, 2024 2:21 AM

Oct 14 (Reuters) - The World Health Organization said on

Monday it had approved Bavarian Nordic's ( BVNKF ) mpox vaccine

for adolescents aged 12 to 17 years, an age group considered

especially vulnerable to outbreaks of the disease that has

triggered global concern.

Previous page： --Boeing, Airbus Vying for Big Riyadh Air Widebody Order, Bloomberg Reports Next page： Brazil's Gol signs deal to convert $950 million in Abra debt into Gol shares

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Boeing, Airbus Vying for Big Riyadh Air Widebody Order, Bloomberg Reports

Nov 9, 2024

08:51 AM EST, 11/06/2024 (MT Newswires) -- Price: 151.83, Change: +0.83, Percent Change: +0.55 ...

Brazil's Gol signs deal to convert $950 million in Abra debt into Gol shares

Nov 9, 2024

SAO PAULO (Reuters) - Brazilian airline Gol said on Wednesday in a securities filing that it has signed a deal with its shareholder Abra to reinforce its current restructuring plan. According to the company, the deal includes the conversion of $950 million in Abra's secured debt into Gol shares. ...

Sector Update: Consumer

Nov 9, 2024

08:51 AM EST, 11/06/2024 (MT Newswires) -- Consumer stocks were higher premarket Wednesday with the Consumer Discretionary Select Sector SPDR Fund (XLY) up nearly 3% and the Consumer Staples Select Sector SPDR Fund (XLP) recently up 0.2%. Celsius Holdings ( CELH ) shares were down more than 5% after the company reported a breakeven in Q3 as revenue declined during...

MFA Financial's Q3 Non-GAAP Earnings Drop

Nov 9, 2024

08:50 AM EST, 11/06/2024 (MT Newswires) -- MFA Financial ( MFA/PB ) reported Q3 non-GAAP earnings Wednesday of $0.37 per diluted share, down from $0.41 a year earlier. Analysts polled by Capital IQ expected $0.41. Net interest income for the quarter ended Sept. 30 was $50.6 million, up from $46.1 million a year earlier. No comparable net interest income estimates...